New Medical Centre Alexandria results, Q1 2024
Net profit, assets, equity and cash flow for Q1 2024, against the same period a year earlier, from the published financial statements.
Net profit2.67 millionEGP · −64.1% vs the same period a year earlier
Total assets313 millionEGP · −0.2% vs the same period a year earlier
Shareholders' equity194 millionEGP · −16.9% vs the same period a year earlier
Operating cash flow14.27 millionEGP · +697.0% vs the same period a year earlier
In short
- New Medical Centre Alexandria's net profit for Q1 2024 was about 2.67 million EGP, down −64.1% from 7.45 million EGP in Q1 2023.
- Total assets at the end of Q1 2024 were about 313 million EGP, and shareholders' equity about 194 million EGP.
- Operating cash flow for Q1 2024 was positive at 14.27 million EGP.
Key lines against the same period a year earlier
This periodQ1 2023Change
Net profit2.67 million7.45 million−64.1%
Gross profit18.8 million88.77 million−78.8%
Total assets313 million314 million−0.2%
Total liabilities119 million80.58 million+48.3%
Shareholders' equity194 million233 million−16.9%
Total liabilities and equity313 million314 million−0.2%
Operating cash flow14.27 million-2.39 million+697.0%
Investing cash flow-1.42 million-2.92 million+51.3%
Financing cash flow—25.16 million—
Net change in cash12.85 million19.85 million−35.3%
Figures in EGP from the published statement summaries (consolidated where the company publishes consolidated statements), after normalising reporting units across periods. The exact figure is in the attached report, which may be the standalone version. Figures are as shown in the published statement summary; quarterly figures may be cumulative from the start of the fiscal year.
New Medical Centre Alexandria's Q3 2026 results, the day they are published
One email on the day, no account, and a one-click stop in the email itself.
By subscribing you agree to receive these alerts only. Privacy policy